Cèsar Milstein

Q: What Schools Are Affiliated With Cèsar Milstein

Cèsar Milstein is affiliated with the following schools: University College London, Duke University

Cèsar Milstein's AcademicInfluence.com Rankings

Cèsar Milstein

Biology

#2198

World Rank

#3521

Historical Rank

Immunology

#70

World Rank

#76

Historical Rank

Molecular Biology

#122

World Rank

#126

Historical Rank

Biochemistry

#170

World Rank

#219

Historical Rank

biology Degrees

Download Badge

Biology

Cèsar Milstein's Degrees

PhD Biochemistry Columbia University

Why Is Cèsar Milstein Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Cèsar Milstein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Continuous cultures of fused cells secreting antibody of predefined specificity (1975) (16547)
Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis (1978) (1957)
Derivation of specific antibody‐producing tissue culture and tumor lines by cell fusion (1976) (1836)
Antibodies to major histocompatibility antigens produced by hybrid cell lines (1977) (1605)
[1] Preparation of monoclonal antibodies: Strategies and procedures (1981) (1411)
Mac‐1: a macrophage differentiation antigen identified by monoclonal antibody (1979) (1129)
Man-made antibodies (1991) (896)
Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. (1988) (882)
Preparation of monoclonal antibodies: strategies and procedures. (1981) (745)
Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytes (1977) (716)
Fusion between immunoglobulin‐secreting and nonsecreting myeloma cell lines (1976) (652)
Mutation Drift and Repertoire Shift in the Maturation of the Immune Response (1987) (630)
Detection of substance P in the central nervous system by a monoclonal antibody. (1979) (584)
Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens (1978) (561)
Somatic mutation and the maturation of immune response to 2-phenyl oxazolone (1984) (523)
A possible precursor of immunoglobulin light chains. (1972) (481)
Hybrid hybridomas and their use in immunohistochemistry (1983) (472)
A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody (1979) (463)
Elements regulating somatic hypermutation of an immunoglobulin κ gene: Critical role for the intron enhancer/matrix attachment region (1994) (398)
Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. (1998) (384)
Rat × rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG (1979) (376)
Molecular events during maturation of the immune response to oxazolone (1985) (369)
Reshaping human antibodies: grafting an antilysozyme activity. (1988) (351)
The Dynamic Nature of the Antibody Repertoire (1988) (313)
A novel family of human major histocompatibility complex-related genes not mapping to chromosome 6 (1986) (302)
Two classes of CD1 genes (1989) (286)
Origin of Antibody Variation (1966) (286)
Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots. (1993) (281)
Kinetic maturation of an immune response (1991) (272)
mRNA sequences define an unusually restricted IgG response to 2-phenyloxazolone and its early diversification (1983) (270)
T-lymphocyte heterogeneity in the rat: separation of functional subpopulations using a monoclonal antibody (1978) (259)
Conformational isomerism and the diversity of antibodies. (1994) (258)
Discriminating intrinsic and antigen-selected mutational hotspots in immunoglobulin V genes. (1993) (236)
Developmental regulation of IgM secretion: The role of the carboxy-terminal cysteine (1990) (235)
Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease. (2000) (228)
Continuous cultures of fused cells secreting antibody of predefined specificity. 1975. (1992) (217)
Targeting of non-lg sequences in place of the V segment by somatic hyper mutation (1995) (213)
Human CD1d–glycolipid tetramers generated by in vitro oxidative refolding chromatography (2001) (206)
Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. (1991) (201)
Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens. (1986) (192)
Codon bias targets mutation (1995) (175)
Both DNA strands of antibody genes are hypermutation targets. (1998) (174)
Immunocytochemical detection of serotonin with monoclonal antibodies. (1981) (172)
Monoclonal antibodies as probes for differentiation and tumor-associated antigens: a Forssman specificity on teratocarcinoma stem cells (1978) (172)
Structure and evolution of immunoglobulins. (1970) (159)
Human immunoglobulin heavy chain genes: evolutionary comparisons of C mu, C delta and C gamma genes and associated switch sequences. (1981) (159)
Mouse CD1 is distinct from and co‐exists with TL in the same thymus. (1988) (158)
Fusion of Two Immunoglobulin-producing Myeloma Cells (1973) (150)
Maturation of the immune response. (1996) (149)
Somatic mutation and the origin of antibody diversity. Clonal variability of the immunoglobulin produced by MOPC 21 cells in culture (1973) (149)
Complete sequence of constant and 3′ noncoding regions of an immunoglobulin mRNA using the dideoxynucleotide method of RNA sequencing (1978) (147)
Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination (2001) (145)
Russell bodies: a general response of secretory cells to synthesis of a mutant immunoglobulin which can neither exit from, nor be degraded in, the endoplasmic reticulum (1991) (141)
Pillars Article: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 1975, 256 (5517): 495–497. (2005) (141)
Nonsense Mutations Inhibit RNA Splicing in a Cell-Free System: Recognition of Mutant Codon Is Independent of Protein Synthesis (1996) (140)
AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization (2002) (138)
Three‐dimensional structure determination of an anti‐2‐phenyloxazolone antibody: the role of somatic mutation and heavy/light chain pairing in the maturation of an immune response. (1990) (134)
Monitoring and interpreting the intrinsic features of somatic hypermutation (1998) (132)
[17] Bispecific monoclonal antibodies from hybrid hybridomas (1986) (131)
Structure and expression of the human thymocyte antigens CD1a, CD1b, and CD1c. (1987) (128)
Immunoglobulins: Structural Studies of Immunoglobulin G (1969) (127)
Structure and biological properties of immunoglobulins. (1967) (126)
A small polypeptide different from β2-microglobin associated with a human cell surface antigen (1979) (123)
Cells strongly expressing Igκ transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers (1997) (120)
Somatic hypermutation of immunoglobulin kappa may depend on sequences 3′ of C kappa and occurs on passenger transgenes. (1991) (119)
Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. (1995) (119)
Hybrid hybridomas and the production of bi-specific monoclonal antibodies. (1984) (116)
Secretion of immunoglobulin M assembly intermediates in the presence of reducing agents (1990) (115)
The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially (2001) (113)
Anti-oxazolone hybridomas and the structure of the oxazolone idiotype. (1983) (106)
Regulation of membrane IgM expression in secretory B cells: translational and post‐translational events. (1987) (106)
Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies. (1980) (105)
Low cytoplasmic mRNA levels of immunoglobulin kappa light chain genes containing nonsense codons correlate with inefficient splicing. (1994) (105)
Analysis of somatic hypermutation in mouse Peyer's patches using immunoglobulin kappa light-chain transgenes. (1993) (104)
Advantages of bispecific hybridomas in one-step immunocytochemistry and immunoassays. (1986) (104)
Sensitive and high resolution in situ hybridization to human chromosomes using biotin labelled probes: assignment of the human thymocyte CD1 antigen genes to chromosome 1. (1988) (101)
The complete amino acid sequence of a mouse ϰ light chain (1972) (101)
Sequence analysis of immunoglobulin light chain messenger RNA (1974) (100)
Intracellular immunoglobulin chain synthesis in non-secreting variants of a mouse myeloma: detection of inactive light-chain messenger RNA. (1974) (97)
Molecular analysis of spontaneous somatic mutants (1977) (96)
The hybridoma revolution: an offshoot of basic research. (1999) (95)
Monoclonal Anti‐A from a Hybrid‐Myeloma: Evaluation as a Blood Grouping Reagent (1980) (94)
Characterization and immunocytochemical application of monoclonal antibodies against enkephalins. (1984) (93)
Partial Deletion in the Heavy Chain Disease Protein ZUC (1969) (92)
Purification and sequence of messenger RNA for immunoglobulin light chains. (1973) (87)
Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries (2018) (87)
An immunoglobulin deletion mutant with implications for the heavy-chain switch and RNA splicing (1980) (86)
A myeloma hybrid producing antibody specific for an allotypic determinant on “IgD‐like” molecules of the mouse (1977) (85)
Memory in the B-cell compartment: antibody affinity maturation. (2000) (84)
The 5′ boundary of somatic hypermutation in a Vχ gene is in the leader intron (1994) (82)
Sequence and evolution of the human T-cell antigen receptor beta-chain genes. (1985) (82)
Activation of memory and virgin B cell clones in hyperimmune animals (1987) (80)
Immunocytochemistry with internally labeled monoclonal antibodies. (1982) (77)
Somatic mutation of immunoglobulin lambda chains: a segment of the major intron hypermutates as much as the complementarity-determining regions. (1994) (77)
Control of HLA‐A,B,C synthesis and expression in interferon‐treated cells. (1982) (76)
Complete sequence of an immunoglobulin mRNA using specific priming and the dideoxynucleotide method of RNA sequencing. (1981) (76)
Variations in the S—S bridges of immunoglobins G: Interchain disulphide bridges of γG3 myeloma proteins (1968) (76)
Human immunoglobulin subclasses. Partial amino acid sequence of the constant region of a gamma 4 chain. (1970) (74)
Transcriptional regulation of HLA-A and -B: differential binding of members of the Rel and IRF families of transcription factors. (1993) (71)
Immunoglobulins: Chemical Typing of Immunoglobulins (1969) (70)
Mutation and selection during the secondary response to 2-phenyloxazolone. (1991) (68)
A physical map linking the five CD1 human thymocyte differentiation antigen genes. (1989) (68)
The discrepancy between the cross-reactivity of a monoclonal antibody to serotonin and its immunohistochemical specificity. (1983) (66)
Chapter 1 The Use of Monoclonal Antibody Techniques in the Study of Developing Cell Surfaces (1980) (66)
Studies on polysome-membrane interactions in mouse myeloma cells. (1974) (65)
Somatic cell genetics of antibody-secreting cells: studies of clonal diversification and analysis by cell fusion. (1977) (65)
The targeting of somatic hypermutation. (1996) (65)
Use of monoclonal antibodies in immunocytochemistry with special reference to the central nervous system (1980) (62)
Modifying the sequence of an immunoglobulin V-gene alters the resulting pattern of hypermutation. (1996) (61)
Original and artificial antibodies (1992) (59)
Light chain germ‐line genes and the immune response to 2‐phenyloxazolone. (1985) (59)
Serum β2-microglobulin binds to a T-cell differentiation antigen and increases its expression (1984) (58)
Bispecific monoclonal antibodies from hybrid hybridomas. (1986) (57)
The disulphide bridges of a mouse immunoglobulin G1 protein. (1972) (57)
A Progressive Deposition of Paired Helical Filaments (PHF) in the Brain Characterizes the Evolution of Dementia in Alzheimer's Disease.: An Immunocytochemical Study with a Monoclonal Antibody Against the PHF Core (1991) (57)
Expression of CD1 in the mouse thymus (1990) (54)
Junctional diversity is essential to antibody activity. (1984) (53)
Stability of cytoplasmic ribonucleic acid in a mouse myeloma: estimation of the half-life of the messenger RNA coding for an immunoglobulin light chain. (1974) (52)
Analysis of antibody diversity: V‐D‐J mRNA nucleotide sequence of four anti‐GAT monoclonal antibodies. A paucigene system using alternate D‐J recombinations to generate functionally similar hypervariable regions. (1983) (52)
The 5′ hypermutation boundary of x chains is independent of local and neighbouring sequences and related to the distance from the initiation of transcription (1997) (50)
Stimulation of HLA‐A,B,C by IFN‐alpha. The derivation of Molt 4 variants and the differential expression of HLA‐A,B,C subsets. (1985) (49)
From antibody structure to immunological diversification of immune response. (1986) (48)
Alternative splicing generates secretory isoforms of human CD1. (1994) (48)
With the benefit of hindsight. (2000) (47)
Somatic hypermutation. (1995) (47)
Variability of Interchain Binding of Immunoglobulins: Interchain Bridges of Mouse IgG2a and IgG2b (1970) (46)
The identification of the β2‐microglobulin binding antigen encoded by the human CDID gene (1991) (45)
Attempted targeting of a monoclonal antibody in a human tumour xenograft system. (1981) (45)
Age‐related decrease in the proportion of germinal center B cells from mouse Peyer's patches is accompanied by an accumulation of somatic mutations in their immunoglobulin genes (1994) (44)
Antibody diversity (1974) (44)
Monoclonal antibodies and cell surface antigens. (1979) (44)
Somatic Mutants and Antibody Diversity (1977) (43)
The genetic basis of antibody specificity. (1970) (43)
The molecular biology of CD1. (2000) (43)
Inter Heavy–Light Chain Disulphide Bridge in Immune Globulins (1967) (42)
Possible role for the Fc receptor on B lymphocytes (1974) (42)
Colony assays for antibody fragments expressed in bacteria. (1991) (42)
Fusion of T and B cells (1977) (41)
Translation of messenger RNA for immunoglobulin light chains in a cell‐free system from Krebs II ascites cells (1972) (41)
Luminescent detection method for immunodot, Western, and Southern blots. (1986) (41)
Characterisation of the first monoclonal antibody against the pronase resistant core of the Alzheimer PHF. (1989) (40)
Disulphide Bridges of Immunoglobin G1 Heavy Chains (1967) (39)
Intrachain disulphide bridges in immunoglobulin G heavy chains. The Fc fragment. (1968) (37)
Affinity maturation leads to differential expression of multiple copies of a κ light-chain transgene (1993) (36)
Mouse immunoglobulin genes: studies on the reiteration frequency of light-chain genes by hybridisation procedures. (1975) (36)
Structure of Antibody Molecules (1967) (35)
Studies on the Variability of Immunoglobulin Sequence (1967) (35)
Use of a monoclonal antibody specifically non-reactive with T cells to delineate lymphocyte subpopulations. (1981) (34)
Non‐random features of the repertoire expressed by the members of one Vx gene family and of the V‐J recombination (1992) (34)
Expression of spleen cell immunoglobulin phenotype in hybrids with myeloma cell lines (1981) (34)
Monoclonal anti-A and anti-B: development as cost-effective reagents. (1982) (34)
Disulphide bridges of the heavy chain of human immunoglobulin G2. (1971) (34)
The Wellcome Foundation Lecture, 1980 - Monoclonal antibodies from hybrid myelomas (1981) (33)
Monoclonal anti-rat MHC (H-1) alloantibodies. (1978) (33)
Spontaneous mutation in tissue culture — chemical nature of variant immunoglobulin from mutant clones of MOPC 21 (1973) (33)
Anomalous phenotype in thymic acute lymphoblastic leukaemia (1980) (32)
Lack of somatic mutation in a χ light chain transgene (1990) (32)
Variability of Interchain Binding of Immunoglobulins: Interchain Bridges of Human IgD (1970) (32)
Analysis of immunoglobulin chain secretion using hybrid myelomas (1980) (30)
Essential role of thiol groups in aldehyde dehydrogenases. (1957) (29)
The translation in vitro of mRNA for immunoglobulin heavy chains. (1973) (29)
Recovery of the genome of murine sarcoma virus (MSV) after infection of cells with nuclear DNA from MSV transformed non-virus producing cells. (1973) (28)
The rabbit CD1 and the evolutionary conservation of the CD1 gene family. (1989) (28)
SEROTONIN IMMUNOREACTIVITY IN CARCINOID TUMOURS DEMONSTRATED BY A MONOCLONAL ANTIBODY (1982) (28)
Chemical structure of light chains (1966) (28)
An oscillating bubble chamber for laboratory scale production of monoclonal antibodies as an alternative to ascitic tumours. (1992) (27)
The Croonian Lecture, 1989 Antibodies: a paradigm for the biology of molecular recognition (1990) (27)
H9/25 monoclonal antibody recognizes a new allospecificity of mouse lymphocyte subpopulations: Strain and tissue distribution (1980) (27)
Expansion and Contraction in the Evolution of Immunoglobulin Gene Pools (1971) (27)
Disulphide Bridges of a Human Immunoglobulin G Protein (1967) (27)
From the Structure of Antibodies to the Diversification of the Immune Response (1985) (26)
Preparation of immunologlobulin light-chain mRNA from microsomes without the use of detergent. (1974) (25)
Demonstration that a mouse immunoglobulin light chain messenger RNA hybridizes exclusively with unique DNA (1975) (25)
C-Terminal Half of Immunoglobulin λ Chains (1967) (25)
Purification and sequence analysis of the mRNA coding for an immunoglobulin heavy chain. (1976) (24)
Isolation of six monoclonal alloantibodies against rat histocompatibility antigens: clonal competition. (1980) (24)
Nucleotide sequence of an HLA-Bw57 gene. (1990) (24)
The 5' boundary of somatic hypermutation in a V kappa gene is in the leader intron. (1994) (23)
Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis (2022) (23)
A single-step procedure for cloning and selection of antibody-secreting hybridomas. (1990) (23)
Monoclonal xenogeneic antibodies to mouse leukocyte antigens: identification of macrophage-specific and other differentiation antigens. (1978) (22)
3 – The maturation of the antibody response (1995) (21)
Automatic monitoring of biochemical parameters in tissue culture. Studies on synchronously growing mouse myeloma cells. (1972) (21)
Optimism after much pessimism: what next? (1999) (21)
Structural studies of immunoglobulin G. (1969) (20)
Molecular characterization of a nonsecreting myeloma mutant (1983) (20)
In vivo and in vitro studies of immunoglobulin gene somatic hypermutation. (2001) (20)
Intracellular processing of membrane and secreted immunoglobulin delta-chains. (1984) (19)
Sequence analysis of the 3' non-coding region of mouse immunoglobulin light chain messenger RNA. (1977) (19)
Clonal competition and stability of hybrid myelomas of mouse and rat origin. (1980) (18)
The identification of the beta 2-microglobulin binding antigen encoded by the human CD1D gene. (1991) (17)
Universal cloning and direct sequencing of rearranged antibody V genes using C region primers, biotin-captured cDNA and one-side PCR. (1995) (17)
Chemical typing of human kappa light chain subgroups expressed by human hybrid myelomas. (1982) (17)
Monoclonal antibodies and cell surface antigens. (1979) (16)
A mouse immunoglobulin heavy chain deletion mutant: isolation of a cDNA clone and sequence analysis of the mRNA. (1980) (16)
From the Structure of Antibodies to the Diversification of the Immune Responce (Noble Lecture) (1985) (16)
Somatic variants of the level of expression of a cell surface antigen. (1983) (15)
Monoclonal antibody H 9/25 reacts with functional subsets of T and B cells: killer, killer precursor and plaque‐forming cells (1980) (15)
The rabbitCD1 and the evolutionary conservation of theCD1 gene family (2006) (15)
A reporter gene to analyse the hypermutation of immunoglobulin genes. (1995) (15)
General motors cancer research foundation awards (1982) (15)
The secretion of a sialic acid‐free immunoglobulin (1973) (15)
Quantitation of antibody genes by molecular hybridization. (1977) (14)
Mouse immunoglobulin subclasses: cyanogen bromide fragments and partial sequence of a gamma1 chain. (1975) (14)
The Analysis of Structural Diversity in the Antibody Response (1985) (14)
Human immunoglobulin E. The primary structure of the C‐terminal domain of the epsilon chain (1973) (14)
Preliminary crystallographic study of the Fab fragments of two monoclonal anti-2-phenyloxazolone antibodies. (1985) (13)
Interchain bridges of mouse IgG1. (1970) (13)
Diversity and the genesis of high affinity antibodies. (1987) (12)
A direct antigen-binding assay to screen hybridoma supernatants. (1985) (12)
Phorbol esters potentiate the induction of class I HLA expression by interferon alpha. (1989) (11)
Chemical typing of immunoglobulins. (1969) (10)
Two steps in the intracellular transport of IgD are sensitive to energy depletion. (1989) (10)
H 9/25 monoclonal antibody recognizes a new allospecificity of mouse lymphocyte subpopulations: strain and tissue distribution. (1980) (9)
The complete amino acid sequence of a mouse kappa light chain. (1972) (9)
Cosmid cloning and walking to map human CD1 leukocyte differentiation antigen genes. (1993) (9)
A simple procedure for the fractionation of the tryptic peptides of the C-terminal half of immunoglobulin lambda-chains. (1968) (9)
Immunoglobulin genes undergo multiple sequence rearrangements during differentiation. (1981) (9)
IMMUNOGLOBULIN GENES IN A MOUSE MYELOMA AND IN MUTANT CLONES (1975) (8)
Molecular events during the onset and maturation of the antibody response. (1986) (8)
Immunoreactive precipitation of protein components after isoelectric focusing. (1973) (8)
Non-random features of the repertoire expressed by the members of one V kappa gene family and of the V-J recombination. (1992) (8)
Development of a monoclonal antibody against a neuroactive peptide: immunocytochemical applications. (1980) (7)
Affinity maturation leads to differential expression of multiple copies of a κ light-chain transgene (1995) (7)
Variability of Interchain Binding of Immunoglobulins: Interchain Bridges of Mouse IgG1 (1970) (7)
The Cell-Free Synthesis of Immunoglobulin Chains (1973) (7)
From the Structure of Antibodies to the Diversification of the Immune Response (1993) (6)
Letter: Fusion of two immunoglobulin-producing myeloma cells. (1973) (6)
From the structure of antibodies to the diversification of the immune response (1985) (6)
General Discussion on Theories of Antibody Variability (1967) (6)
Immunoglobulin Gene Expression (1988) (6)
Lack of somatic mutation in a kappa light chain transgene. (1990) (6)
Spontaneous somatic frameshift mutation in a mouse myeloma. (1978) (5)
The parallel nature of the interchain disulphide bonds of immunoglobulins. Studies on a mouse IgG1 myeloma protein. (1972) (5)
Messenger Ribonucleic Acids from Mutant Myeloma Cells (1975) (5)
Investigation of the genetic diversity of mouse immunoglobulin kappa-chain genes. (1975) (5)
Chromosome segregation and expression of rat immunoglobulins in rat/mouse hybrid myelomas (2005) (5)
The induction of class I HLA by interferon‐α is independent of the cell cycle, but the expression is enhanced by a G1/S block (1987) (5)
Spontaneous missense mutation of an immunoglobulin in a mouse myeloma cell line. (1977) (5)
Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies (2021) (5)
Development and application of a monoclonal rat peroxidase antiperoxidase (PAP) immunocytochemical reagent (2004) (5)
ACCURACY IN HISTOLOGICAL DIAGNOSIS OF CARCINOID TUMOURS (1982) (4)
Variations in the S-S bridges of immunoglobins G: interchain disulfide bridges of gamma G3 myeloma proteins. (1968) (4)
Expression of antibody genes in tissue culture: structural mutants and hybrid cells. (1978) (4)
The Impact of Monoclonal Antibodies on Studies of the Differentiation of Lymphocytes (1984) (4)
Kinetics of the potassium-activated aldehyde dehydrogenase of yeast. (1958) (4)
The regulation of membrane-bound and secreted immunoglobulins in the human lymphoid cell line LICR-LON and human hybridomas. (1987) (3)
The effect of interferon on the expression of human cell-surface antigens. (1982) (3)
mRNA sequences define an unusually restricted IgG response to oxazolone. (1984) (3)
Specific protection of the thiol groups of aldehyde dehydrogenases by pyridine-nucleotide coenzymes. (1957) (3)
Effect of purified human interferon-alpha on the expression of differentiation antigens and mitogen reactivity of cultured human thymic cells. (1986) (2)
Molecular analysis of spontaneous somatic mutants. (review). (1977) (2)
Nomenclature of immunological markers (1987) (2)
MESSING ABOUT WITH ISOTOPES AND ENZYMES AND ANTIBODIES (1982) (2)
[Clonal variations of myelomatous cells (proceedings)]. (1977) (2)
Immunoglobulin mRNA and Immunoglobulin Genes (1976) (2)
The use of monoclonal antibody techniques in the study of development cell surfaces. (1980) (2)
IMMUNOCYTOCHEMISTRY WITH MONOCLONAL ANTIBODIES: POTENTIAL APPLICATIONS IN BASIC SCIENCES AND HISTOPATHOLOGY (1982) (2)
The Variability of Human Immunoglobulins (1970) (2)
“ANALYSIS OF SOMATIC CELL MUTATIONS AT THE GLYCOPHORIN-A LOCUS IN HUMAN ERYTHROCYTES (2014) (1)
What's new: Hybridoma technology in immunocytochemistry (1984) (1)
SPONTANEOUS MUTATION IN IMMUNOGLOBULIN GENES (1974) (1)
From antibody genes to the analysis of differentiation antigens. (1979) (1)
Biological properties of immunogiobulins (1979) (1)
Clonal Diversification of Antibody-Producing Cells in Culture (1977) (1)
George Jean Franz Köhler — a personal tribute (1996) (1)
Pillars Article: Origin of antibody variation. Nature 1966. 211: 242-243. (2006) (1)
Continuous cultures of fused cells secreting antibody of predefined specificity. 1975. (2005) (1)
[Effect of acetaldehyde on inhibition of aldehydedehydrogenase by thio-reagents]. (1957) (0)
Regulation of somatic hypermutation (1997) (0)
[Specific protection by pyridine-adenine dinucleotides of essential thiols in aldehyde dehydrogenases]. (1957) (0)
Isolation of CD 1 genes : A family of major histocompatibility complex-related differentiation antigens ( leukocyte differentiation antigen / thymus leukemia antigen / multigene-family evolution / 1 P 2-microglobulin ) (0)
Histil rottemyelomacellelinie unknown, the hybrid cell line derived therefrom, in vitro cell culture system and the cell fusion system comprising cells therefrom, method of making a hybrid cell line as well as the process for the preparation of monoclonal antibodies (1980) (0)
C-terminal half of immunoglobulin lambda-chains. (1967) (0)
Certain Ig mutants induce formation of Russell bodies in myeloma and glioma cells (1990) (0)
Monoclonal Antibodies and Neurotransmitters (1982) (0)
Subclinical hypothyroidism. To treat or not to treat. (1993) (0)
[Influence of cations on the sensitivity of aldehyde dehydrogenases by thiol reagents]. (1957) (0)
Variability of immunoglobulins. (1974) (0)
The green platform for a new generation of vaccines (2012) (0)
[Effects of cations on sensitivity of aldehyde-dehydrogenase to sulfhydryl reagents]. (1957) (0)
Table of Contents (1990) (0)
[Effect of acetaldehyde on inhibition of aldehyde dehydrogenases by thiol reactants]. (1957) (0)
Factores epigenéticos en mujeres embarazadas con diabetes Epigenetic Factors in Pregnant Women with Diabetes (2014) (0)
The deleterious effect of polyglutamine aggregation in cell models of Huntington's disease. (2000) (0)
Production of antibody (1990) (0)
Human IgD, the Gene and the Protein (1982) (0)
A MONOCLONAL ANTIBODY AGAINST THE PRONASE RESISTANT CORE OF THE PHF (1988) (0)
WorkshopReducing agents induce secretion of IgM assembly intermediates (1990) (0)
Both DNA strands of antibody gi (0)
[Enzyme-substrate complexes of diphosphopyridine nucleotide-linked aldehyde dehydrogenase of yeast]. (1957) (0)
Dideoxy mRNA Sequencing as a Method to Analyze Antibody Diversity (1985) (0)
Is beta t a component of HLA-A,B,C in thymus derived cells? (1983) (0)
Immunoglobulin lambda-chains. The complete amino acid sequence of a Bence-Jones protein. (1968) (0)
Studies on mRNA Sequence and Immunoglobulin Gene Organization Using Synthetic Oligonucleotides (1979) (0)
Messenger rna sequences define an unusually restricted immuno globulin g response to oxazolone (1984) (0)
A Signal for Protein Secretion (2004) (0)
Expression and Characterization of Leucocyte Antigens (1984) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Cèsar Milstein?

Cèsar Milstein is affiliated with the following schools:

Cèsar Milstein's Academic­Influence.com Rankings

Cèsar Milstein's Degrees

Why Is Cèsar Milstein Influential?

Cèsar Milstein's Published Works

Published Works

What Schools Are Affiliated With Cèsar Milstein?

Cèsar Milstein's AcademicInfluence.com Rankings